Pediatric Cancer Amendment Pulled From User Fee Markup, Talks Ensue

By Beth Wang / May 11, 2017 at 6:13 PM
Sen. Michael Bennett (D-CO) withdrew from Thursday's user fee markup his revised bill that aims to promote further research on pediatric cancer treatments, telling the Senate health committee that “we’re not in a place today to adopt the amendment.” A source close to the negotiations told Inside Health Policy that some provisions in the bill were included in the user fee manager’s amendment, and the rest of the provisions and recommendations from FDA are still being looked at. Bennet...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.